John J Hermans
Overview
Explore the profile of John J Hermans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong M, van Delft F, Radstake F, Perik T, Litjens G, Bisseling T, et al.
Pancreatology
. 2025 Feb;
PMID: 39909762
Background: Pancreatic ductal adenocarcinoma (PDAC) still has a dismal 5-year overall survival of 13 %. Chemotherapy is increasingly used as treatment in both (neo-) adjuvant and palliative conditions. However, the...
2.
Maatman I, Maas M, Ypma S, Block T, van den Elshout R, Veltien A, et al.
Invest Radiol
. 2025 Jan;
PMID: 39761203
Objectives: Accurate lymph node (LN) staging is crucial for managing upper abdominal cancers. Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging effectively distinguishes healthy and metastatic LNs through fat/water and...
3.
Bond M, Bolhuis K, Loosveld O, de Groot J, Droogendijk H, Helgason H, et al.
JAMA Oncol
. 2024 Nov;
11(1):36-45.
PMID: 39570583
Importance: In patients with colorectal cancer and unresectable liver-only metastases (CRLM), treatment with folinic acid, fluorouracil, and oxaliplatin (FOLFOX) plus irinotecan (FOLFOXIRI) and bevacizumab vs FOLFOX/folinic acid, fluorouracil, and irinotecan...
4.
Michiel Zeeuw J, Wesdorp N, Ali M, Bakker A, Voigt K, Starmans M, et al.
Eur J Cancer
. 2024 Jun;
207:114185.
PMID: 38924855
Background: This study aimed to assess the prognostic value of total tumor volume (TTV) for early recurrence (within 6 months) and overall survival (OS) in patients with colorectal liver metastases...
5.
Litjens G, Nakamoto A, Brosens L, Maas M, Scheenen T, Zamecnik P, et al.
Eur Radiol
. 2024 Jun;
34(12):7973-7984.
PMID: 38907886
Objectives: To assess 3-Tesla (3-T) ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI in detecting lymph node (LN) metastases for resectable adenocarcinomas of the pancreas, duodenum, or periampullary region in a node-to-node...
6.
Maatman I, Schulz J, Ypma S, Block K, Schmitter S, Hermans J, et al.
NMR Biomed
. 2024 May;
37(10):e5180.
PMID: 38775032
Ultrahigh field magnetic resonance imaging (MRI) (≥ 7 T) has the potential to provide superior spatial resolution and unique image contrast. Apart from radiofrequency transmit inhomogeneities in the body at...
7.
Riviere D, Maas M, Brosens L, Stommel M, van Laarhoven C, Hermans J
Diagnostics (Basel)
. 2024 Mar;
14(6).
PMID: 38534994
This study evaluated the relationship between apparent diffusion coefficient (ADC) values in pancreatic ductal adenocarcinoma (PDAC) and tumor grades based on WHO, Adsay, and Kalimuthu classifications, using whole-mount pancreatectomy specimens....
8.
Perik T, Alves N, Hermans J, Huisman H
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339328
Methods: From January 2018 to November 2022, 107 PDAC patients were prospectively included, who needed to undergo CTP and a diagnostic contrast-enhanced CT (CECT). We developed a semi-automated CTP AI...
9.
Wesdorp N, Michiel Zeeuw J, Postma S, Roor J, van Waesberghe J, van den Bergh J, et al.
Eur Radiol Exp
. 2023 Dec;
7(1):75.
PMID: 38038829
Background: We developed models for tumor segmentation to automate the assessment of total tumor volume (TTV) in patients with colorectal liver metastases (CRLM). Methods: In this prospective cohort study, pre-...
10.
Litjens G, Broekmans J, Boers T, Caballo M, van den Hurk M, Ozdemir D, et al.
Diagnostics (Basel)
. 2023 Oct;
13(20).
PMID: 37892019
The preoperative prediction of resectability pancreatic ductal adenocarcinoma (PDAC) is challenging. This retrospective single-center study examined tumor and vessel radiomics to predict the resectability of PDAC in chemo-naïve patients. The...